Snahlata Singh

713 total citations
14 papers, 468 citations indexed

About

Snahlata Singh is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Snahlata Singh has authored 14 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Snahlata Singh's work include Cancer Immunotherapy and Biomarkers (2 papers), Immune Cell Function and Interaction (2 papers) and Regulation of Appetite and Obesity (2 papers). Snahlata Singh is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Immune Cell Function and Interaction (2 papers) and Regulation of Appetite and Obesity (2 papers). Snahlata Singh collaborates with scholars based in India and United States. Snahlata Singh's co-authors include Rumela Chakrabarti, Manoj Kumar Bhat, Surbhi Chouhan, Dipti Athavale, Rumela Chakrabarti, Ajeya Nandi, Pranay Ramteke, Vimal Pandey, Shyamananda Singh Mayengbam and Andrés Blanco and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Nature Cell Biology.

In The Last Decade

Snahlata Singh

14 papers receiving 465 citations

Peers

Countries citing papers authored by Snahlata Singh

Since Specialization

Citations

This map shows the geographic impact of Snahlata Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Snahlata Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Snahlata Singh more than expected).

Fields of papers citing papers by Snahlata Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Snahlata Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Snahlata Singh. The network helps show where Snahlata Singh may publish in the future.

Co-authorship network of co-authors of Snahlata Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Snahlata Singh. A scholar is included among the top collaborators of Snahlata Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Snahlata Singh. Snahlata Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Challenges of Using IFNγ in Clinical Settings 2023 ·Cancer Research ·Snahlata Singh, Rumela Chakrabarti	6
2	Immature natural killer cells promote progression of triple-negative breast cancer 2023 ·Science Translational Medicine ·Gatha Thacker, (unknown), Ajeya Nandi, (unknown), Snahlata Singh, Anupma Nayak, Barbara Susnik, (unknown), Qing Zhang, Susan B. Kesmodel, Sanjeev Gumber, Gokul M. Das, Taku Kambayashi, Camila O. dos Santos, Rumela Chakrabarti	51
3	Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway 2021 ·Nature Communications ·Sushil Kumar, Ajeya Nandi, Snahlata Singh, (unknown), Ning Li, John W. Tobias, Christian W. Siebel, Andrés Blanco, Andres J. Klein–Szanto, Christopher J. Lengner, Alana L. Welm, Yibin Kang, Rumela Chakrabarti	52
4	Author Correction: Loss of ELF5–FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling 2021 ·Nature Cell Biology ·Snahlata Singh, Sushil Kumar, (unknown), Ajeya Nandi, Gatha Thacker, (unknown), (unknown), (unknown), John W. Tobias, Andrés Blanco, (unknown), M. Raza Zaidi, Satrajit Sinha, Luca Busino, Serge Y. Fuchs, Rumela Chakrabarti	1
5	Loss of ELF5–FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling 2020 ·Nature Cell Biology ·Snahlata Singh, Sushil Kumar, (unknown), Ajeya Nandi, Gatha Thacker, (unknown), (unknown), (unknown), John W. Tobias, Andrés Blanco, (unknown), M. Raza Zaidi, Satrajit Sinha, Luca Busino, Serge Y. Fuchs, Rumela Chakrabarti	80
6	Sensitization of hepatocellular carcinoma cells towards doxorubicin and sorafenib is facilitated by glucose-dependent alterations in reactive oxygen species, P-glycoprotein and DKK4 2020 ·Journal of Biosciences ·Surbhi Chouhan, Snahlata Singh, Dipti Athavale, Pranay Ramteke, Muralidharan Vanuopadath, Bipin G. Nair, Sudarslal Sadasivan Nair, Manoj Kumar Bhat	26
7	Role of TNFα and leptin signaling in colon cancer incidence and tumor growth under obese phenotype 2019 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Snahlata Singh, Shyamananda Singh Mayengbam, Surbhi Chouhan, (unknown), Pranay Ramteke, Dipti Athavale, Manoj Kumar Bhat	18
8	Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells 2019 ·Journal of Clinical Medicine ·Snahlata Singh, Rumela Chakrabarti	53
9	A new Elf5^Cre^ERT^2‐^GFP BAC transgenic mouse model for tracing Elf5 cell lineages in adult tissues 2019 ·FEBS Letters ·Snahlata Singh, (unknown), N. Adrian Leu, Rose‐Anne Romano, Andrew E. Vaughan, (unknown), Kameswaran Surendran, Rumela Chakrabarti	4
10	Elevated circulatory levels of leptin and resistin impair therapeutic efficacy of dacarbazine in melanoma under obese state 2018 ·SHILAP Revista de lepidopterología ·Parmanand Malvi, Balkrishna Chaube, Shivendra V. Singh, Naoshad Mohammad, Maleppillil Vavachan Vijayakumar, Snahlata Singh, Surbhi Chouhan, Manoj Kumar Bhat	49
11	Hepatocellular carcinoma-associated hypercholesterolemia: involvement of proprotein-convertase-subtilisin-kexin type-9 (PCSK9) 2018 ·SHILAP Revista de lepidopterología ·Dipti Athavale, Surbhi Chouhan, Vimal Pandey, Shyamananda Singh Mayengbam, Snahlata Singh, Manoj Kumar Bhat	39
12	SMAR1 inhibits Wnt/β-catenin signaling and prevents colorectal cancer progression 2018 ·Oncotarget ·Nandaraj Taye, Aftab Alam, Suvankar Ghorai, (unknown), (unknown), (unknown), Snahlata Singh, Pallabi Sengupta, Subhrangsu Chatterjee, Manoj Kumar Bhat, Manas Kumar Santra, (unknown), (unknown), Samit Chattopadhyay	23
13	Constitutively activated ERK sensitizes cancer cells to doxorubicin: Involvement of p53-EGFR-ERK pathway 2017 ·Journal of Biosciences ·Ratna Kumari, Surbhi Chouhan, Snahlata Singh, Rishi Raj Chhipa, Amrendra K. Ajay, Manoj Kumar Bhat	23
14	Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4 2016 ·Scientific Reports ·Surbhi Chouhan, Snahlata Singh, Dipti Athavale, Pranay Ramteke, Vimal Pandey, Jomon Joseph, (unknown), (unknown), Manoj Kumar Bhat	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact